141 related articles for article (PubMed ID: 29315115)
1. Brief Report: Racial Comparison of D-Dimer Levels in US Male Military Personnel Before and After HIV Infection and Viral Suppression.
OʼBryan TA; Agan BK; Tracy RP; Freiberg MS; Okulicz JF; So-Armah K; Ganesan A; Rimland D; Lalani T; Deiss RG; Tramont EC
J Acquir Immune Defic Syndr; 2018 Apr; 77(5):502-506. PubMed ID: 29315115
[TBL] [Abstract][Full Text] [Related]
2. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.
Freiberg MS; Bebu I; Tracy R; So-Armah K; Okulicz J; Ganesan A; Armstrong A; O'Bryan T; Rimland D; Justice AC; Agan BK;
PLoS One; 2016; 11(4):e0152588. PubMed ID: 27088215
[TBL] [Abstract][Full Text] [Related]
3. Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya.
Teasdale CA; Hernandez C; Zerbe A; Chege D; Hawken M; El-Sadr WM
BMC Infect Dis; 2020 Jul; 20(1):508. PubMed ID: 32664854
[TBL] [Abstract][Full Text] [Related]
4. Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care.
Weintrob AC; Grandits GA; Agan BK; Ganesan A; Landrum ML; Crum-Cianflone NF; Johnson EN; Ordóñez CE; Wortmann GW; Marconi VC;
J Acquir Immune Defic Syndr; 2009 Dec; 52(5):574-80. PubMed ID: 19755913
[TBL] [Abstract][Full Text] [Related]
5. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
Baker JV; Neuhaus J; Duprez D; Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon DE; Paton NI; Neaton JD;
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):36-43. PubMed ID: 20930640
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus RNA levels in US adults: a comparison based upon race and ethnicity.
Brown AE; Malone JD; Zhou SY; Lane JR; Hawkes CA
J Infect Dis; 1997 Sep; 176(3):794-7. PubMed ID: 9291336
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
Kiefer EM; Hoover DR; Shi Q; Dusingize JC; Sinayobye JD; Anastos K
HIV Med; 2018 Nov; 19(10):734-744. PubMed ID: 30160347
[TBL] [Abstract][Full Text] [Related]
8. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.
Hamlyn E; Fidler S; Stöhr W; Cooper DA; Tambussi G; Schechter M; Miro JM; Mcclure M; Weber J; Babiker A; Porter K;
AIDS; 2014 Mar; 28(6):869-74. PubMed ID: 24300544
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
[TBL] [Abstract][Full Text] [Related]
12. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
Tenorio AR; Zheng Y; Bosch RJ; Krishnan S; Rodriguez B; Hunt PW; Plants J; Seth A; Wilson CC; Deeks SG; Lederman MM; Landay AL
J Infect Dis; 2014 Oct; 210(8):1248-59. PubMed ID: 24795473
[TBL] [Abstract][Full Text] [Related]
13. Baseline clinical characteristics, antiretroviral therapy use, and viral load suppression among HIV-positive young men of color who have sex with men.
Hightow-Weidman LB; Jones K; Phillips G; Wohl A; Giordano TP;
AIDS Patient Care STDS; 2011 Aug; 25 Suppl 1(Suppl 1):S9-14. PubMed ID: 21711145
[TBL] [Abstract][Full Text] [Related]
14. The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System.
Horberg MA; Hurley LB; Klein DB; Towner WJ; Kadlecik P; Antoniskis D; Mogyoros M; Brachman PS; Remmers CL; Gambatese RC; Blank J; Ellis CG; Silverberg MJ
AIDS Patient Care STDS; 2015 Nov; 29(11):582-90. PubMed ID: 26505968
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with D-dimer levels in HIV-infected individuals.
Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD; ; ;
PLoS One; 2014; 9(3):e90978. PubMed ID: 24626096
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: Prevalence of Posttreatment Controller Phenotype Is Rare in HIV-Infected Persons After Stopping Antiretroviral Therapy.
Perkins MJ; Bradley WP; Lalani T; Agan BK; Whitman TJ; Ferguson TM; Okulicz JF; Ganesan A
J Acquir Immune Defic Syndr; 2017 Jul; 75(3):364-369. PubMed ID: 28394856
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
[TBL] [Abstract][Full Text] [Related]
19. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.
Dombrowski JC; Kitahata MM; Van Rompaey SE; Crane HM; Mugavero MJ; Eron JJ; Boswell SL; Rodriguez B; Mathews WC; Martin JN; Moore RD; Golden MR
J Acquir Immune Defic Syndr; 2013 Jul; 63(3):299-306. PubMed ID: 23572013
[TBL] [Abstract][Full Text] [Related]
20. Patient and Facility Correlates of Racial Differences in Viral Control for Black and White Veterans with HIV Infection in the Veterans Administration.
Vaughan Sarrazin MS; Ohl ME; Richardson KK; Asch SM; Gifford AL; Bokhour BG
AIDS Patient Care STDS; 2018 Mar; 32(3):84-91. PubMed ID: 29620926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
